Dergiler / Medicine Science / 2014 / Cilt: 3 - Sayı: 2

The Effect of Trandolapril on Insulin Resistance is Determined by the Degree of Baseline Resistance Level

Sayfa
1140–1154
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In conclusion, trandolapril improved insulin sensitivity better in type 2 diabetic hypertensive patients with higher degree of IR compared with the ones with low grade IR, being independent of its hemodynamic action

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Insulin resistance (IR) is the core problem in type 2 diabetes mellitus that may lead to cardiovascular morbidity and mortality.
📊
Temel Bulgular & Veri:Hypertension commonly accompanies type 2 diabetes.
💡
Sonuç & Katkı:In conclusion, trandolapril improved insulin sensitivity better in type 2 diabetic hypertensive patients with higher degree of IR compared with the ones with low grade IR, being independent of its hemodynamic action
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Insulin resistance (IR) is the core problem in type 2 diabetes mellitus that may lead to cardiovascular morbidity and mortality. Hypertension commonly accompanies type 2 diabetes. Antihypertensive agents improving IR may reduce the risk of cardiovascular diseases. This study was conducted to assess the effect of trandolapril on IR, glucose and lipid metabolisms in hypertensive subjects with different degrees of IR and investigate the importance of IR level in angiotensin converting enzyme inhibitor response. The subjects were nondiabetic and type 2 diabetic hypertensive patients treated with trandolapril for 12 weeks. Blood pressures (BP) and metabolic parameters were measured in all patients at baseline and after 12 weeks of trandolapril treatment and compared. Trandolapril reduced BP similarly in nondiabetic and diabetic patients. Homeostasis model assessment insulin resistance (HOMA-IR), serum glucose and hemoglobin A1C (A1C) in diabetic patients were higher than nondiabetics. HOMAsignificantly after trandolapril in diabetics, while serum glucose, insulin and A1C remained unchanged. The posttreatment HOMA-IR values were comparable in both groups. Pretreatment HOMA-IR value was found to be associated with HOMA-IR response to trandolapril while changes in BMI, A1C and BPs were unrelated. The patients with a pretreatment HOMA-IR of >4.67 responded better. In conclusion, trandolapril improved insulin sensitivity better in type 2 diabetic hypertensive patients with higher degree of IR compared with the ones with low grade IR, being independent of its hemodynamic action

🔖

Bu Makaleye Atıf Yap

ERSOY, C., ERSOY, A., ELBÜKEN, G., TUNCEL, E. (2014). The Effect of Trandolapril on Insulin Resistance is Determined by the Degree of Baseline Resistance Level. Medicine Science, Cilt: 3 - Sayı: 2, 1140–1154. https://ajindex.com/articles/277846

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. 2013;123(7):2764-72
  2. Garcia-Touza M, Sowers JR. Evidence-based hypertension treatment in patients with diabetes. J Clin Hypertens (Greenwich). 2012;14(2):97-102
  3. Miller JL. Insulin resistance syndrome. Description, pathogenesis, and management. Postgrad Med. 2003; Spec No: 27-34
  4. Sharma SK, Ruggenenti P, Remuzzi G. Managing hypertension in diabetic patientsfocus on trandolapril/verapamil combination. Vasc Health Risk Manag. 2007;3(4):453-65
  5. Henriksen EJ, Jacob S. Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance. Diabetes Obes Metab. 2003;5(4):214-22
  6. Rayner B. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful marriage? Curr Med Res Opin. 2004;20(3):359-67
  7. Heinemann L, Heise T, Ampudia J, Sawicki P, Sindelka G, Brunner G, Starke AA. Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity. Eur J Clin Invest. 1995;25(8):595-600
  8. Heise T, Heinemann L, Kristahn K, Berger M, Sawicki PT. Insulin sensitivity in patients with essential hypertension: no influence of the ACE inhibitor enalapril. Horm Metab Res. 1999;31(7):418-23
  9. Park SH, Lee WY, Rhee EJ, Jeon WK, Kim BI, Ryu SH, Kim SW. Relative risks of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults. Clin Sci (Lond). 2005;108(6):553-9
  10. Guay DR. Trandolapril: a newer angiotensin-converting enzyme inhibitor. Clin Ther. 2003;25(3):713-75
  11. Leighton B, Sanderson AL, Young ME, Radda GK, Boehm EA, Clark JF. Effects of treatment of spontaneously hypertensive rats with the angiotensin-converting enzyme inhibitor trandolapril and the calcium antagonist verapamil on the sensitivity of glucose metabolism to insulin in rat soleus muscle in vitro. Diabetes. 1996;45(Suppl.1):S120-4
  12. Jacob S, Henriksen EJ, Fogt DL, Dietze GJ. Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism. 1996;45(5):535- 41
  13. New JP, Bilous RW, Walker M. Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril. Diabet Med. 2000;17(2):134- 40
  14. Petrie JR, Morris AD, Ueda S, Small M, Donnelly R, Conn